Sign in
Enrolling by invitationNo phase

ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients

Key facts

Who runs it
Joan Sabater-Riera
Where
Croatia, France, Greece, Italy, Portugal, and Spain18 sites in 6 countriesChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
500 people, planned
Started
1 May 2025
Expected to end
30 Nov 2026
Type of study
Observational
Record updated
15 May 2026

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients aged 65 years-old or older
  • Patients with clinically and radiologically (Chest X-Ray (CXR), Computerized Tomography (CT) or lung ultrasound (LUS) confirmed pneumonia
  • Patients fulfilling the protocol definition of sCAP

Who cannot take part

  • Patients receiving comfort care only or with documented decisions to forgo intensive medical interventions
  • Age < 65 years
  • Recent hospitalization (above 48 h within the past 10 days) in acute healthcare settings
  • Terminal events or imminent death

Where is this trial?

It has sites in 6 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The ESCAPE 10 study is a multinational, retrospective, observational cohort study that aims to investigate the epidemiology and outcome determinants of severe community-acquired pneumonia (sCAP) in elderly patients (≥65 years). Conducted across multiple European countries, the study will include at least 500 patients admitted to acute care hospitals with radiologically confirmed sCAP, with enrollment distributed evenly between epidemic (winter) and non-epidemic (summer) seasons.

Read full original descriptionShow less

The primary objective is to assess 28-day mortality. Secondary objectives include evaluating in-hospital mortality, pneumonia-related complications, Intensive Care Unit (ICU) stay, ventilation needs, and identifying clinical risk factors associated with poor outcomes. Additionally, the study aims to propose a set of quality indicators for sCAP management and assess gender-related differences and clinical subphenotypes in the post-COVID-19 era.

Data will be retrospectively collected from medical records, with no interventions applied. Findings from this study are expected to guide improvements in clinical care, patient safety, and outcome prediction models in elderly populations with sCAP.

The group in the trial

  • Severe Community-Acquired Pneumonia in the Elderly

    Participants aged 65 years or older who were hospitalized with radiologically confirmed severe community-acquired pneumonia (sCAP), as defined by protocol criteria. All patients included met clinical and radiological criteria for sCAP and were admitted to an acute care hospital during the defined inclusion period.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Escape 10 Study: Epidemiology and Determinants of Outcomes of Severe Community-acquired Pneumonia in the Elderly
Record updated
15 May 2026